Medicus Pharma (MDCX) Change in Account Payables (2024 - 2025)

Medicus Pharma (MDCX) posted Change in Account Payables of -$26604.0 for Q4 2025, down 222.0% quarter-over-quarter from $21807.0 in Q3 2025, and down 104.64% year-on-year from $572989.0 in Q4 2024.

Medicus Pharma (MDCX) Change in Account Payables (2024 - 2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Change in Account Payables for 2 consecutive years, with -$26604.0 the latest figure, recorded in Q4 2025.

  • Change in Account Payables for Q4 2025 came in at -$26604.0, down 104.64% year-over-year; the trailing twelve-month figure through Dec 2025 was -$25983.0 (down 103.21% YoY), and the FY2025 annual result was -$25983.0, down 103.21% from the prior year.
  • Change in Account Payables was -$26604.0 for Q4 2025 at Medicus Pharma, down from $21807.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $572989.0 in Q4 2024 and troughed at -$78116.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 571.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -67.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Medicus Pharma 6.91 Mn -1.69 Mn - -26,604.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -26,604.00
Dec 31, 2025 -26,604.00
Sep 30, 2025 21,807.00
Sep 30, 2025 21,807.00
Jun 30, 2025 3,058.00
Jun 30, 2025 3,058.00
Mar 31, 2025 -24,244.00
Mar 31, 2025 -24,244.00
Dec 31, 2024 572,989.00
Dec 31, 2024 572,989.00
Sep 30, 2024 266,606.00
Sep 30, 2024 266,606.00
Jun 30, 2024 -78,116.00
Jun 30, 2024 -78,116.00
Mar 31, 2024 47,266.00
Mar 31, 2024 47,266.00